237 related articles for article (PubMed ID: 1682737)
1. p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
Ozturk M
Lancet; 1991 Nov; 338(8779):1356-9. PubMed ID: 1682737
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: from gene to public health.
Montesano R; Hainaut P; Wild CP
J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
[TBL] [Abstract][Full Text] [Related]
4. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
5. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
7. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
[TBL] [Abstract][Full Text] [Related]
8. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
Lasky T; Magder L
Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
[TBL] [Abstract][Full Text] [Related]
10. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B
Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
16. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
[TBL] [Abstract][Full Text] [Related]
18. Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa.
Szymańska K; Lesi OA; Kirk GD; Sam O; Taniere P; Scoazec JY; Mendy M; Friesen MD; Whittle H; Montesano R; Hainaut P
Int J Cancer; 2004 Jun; 110(3):374-9. PubMed ID: 15095302
[TBL] [Abstract][Full Text] [Related]
19. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
Gouas D; Shi H; Hainaut P
Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]